Q4 core (adjusted) EPS came in at $1.43, narrowly ahead of the $1.41 adjusted consensus that had been priced in. GAAP diluted EPS of $1.26 was down 15% from the prior-year period, but that figure includes non-core items such as restructuring charges and is not directly comparable to consensus. Net revenue rose 2% from a year earlier to $21.2 billion, and quarterly adjusted free cash flow productivity reached 133%, underscoring continued cash-generation strength.

By segment, Beauty was the brightest spot. Hair care and personal care delivered mid-single-digit growth, and an improved super-premium SK-II mix supported skin care. For the full fiscal year, the company posted revenue of $87 billion (+3%) and core EPS of $6.89 (+1%), growing both the top and bottom lines, while an April dividend increase extended the streak of consecutive dividend hikes to 70 years.

The metric the market was most sensitive to was organic revenue, which looked essentially stalled. Price, volume, and mix were all neutral for the quarter's revenue, and the reported +2% growth was effectively all FX and rounding. Absolute revenue also missed the analyst estimate of $21.377 billion, leaving the growth story looking weak despite the modest earnings beat.

On profitability, core gross margin held steady, but marketing-led reinvestment pushed core SG&A intensity up 130 bp, and core operating margin fell 130 bp. Organic revenue in Baby, Feminine, and Family Care declined 2%, and Health Care (particularly Oral Care) was also weak. The company warned that in FY2027 it faces roughly $1 billion in after-tax headwinds from raw materials, energy, and transportation costs alone, and once net interest expense, non-operating income, and FX are layered in, the total drag rises to about $1.35 billion (roughly $0.56 per share, or about 8% of core EPS), heightening caution around the pace of margin recovery.

CEO Shailesh Jejurikar characterized FY2026 as a year of "foundation-building" in which revenue and earnings continued to grow and shareholder returns continued despite geopolitical and economic headwinds. He went on to say that while volatility will persist into FY2027, the company expects to make progress on its core metrics, and explained that it will more aggressively execute a consumer-first strategy for balanced, sustainable growth, accelerating growth on a half-year cadence. He also stressed that the investment funding will be sourced from productivity programs.

The guidance tone sits closer to a cautious range than an aggressive upgrade. The company guided to FY2027 total and organic revenue growth of 1–3% and core EPS growth of flat to up to 3% (midpoint of $7.00 per share, roughly +1.5%), and explicitly noted that brand, product, and channel prunings will embed a 30–50 bp headwind to organic revenue. The market read this as a message that the foundation has been built, but immediate acceleration is limited.

The narrow beat on core earnings served as a partial cushion, but the revenue miss, organic growth standstill, and cautious annual outlook that reflects cost headwinds carried more weight. Consumer staples majors typically command a "stable growth" premium, and the interpretation that this premise has been shaken this quarter appears to have translated into after-hours selling pressure. There is also still insufficient conviction on whether the marketing reinvestment will translate into share recovery or simply erode margins.